These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30471671)

  • 1. Integrating biocatalysis and multicomponent reactions.
    Lambruschini C; Basso A; Banfi L
    Drug Discov Today Technol; 2018 Nov; 29():3-9. PubMed ID: 30471671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesizing Chiral Drug Intermediates by Biocatalysis.
    Jiang W; Fang B
    Appl Biochem Biotechnol; 2020 Sep; 192(1):146-179. PubMed ID: 32323141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocatalysis for pharmaceutical intermediates: the future is now.
    Pollard DJ; Woodley JM
    Trends Biotechnol; 2007 Feb; 25(2):66-73. PubMed ID: 17184862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrocycles: MCR synthesis and applications in drug discovery.
    Abdelraheem EMM; Shaabani S; Dömling A
    Drug Discov Today Technol; 2018 Nov; 29():11-17. PubMed ID: 30471668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New opportunities for biocatalysis: making pharmaceutical processes greener.
    Woodley JM
    Trends Biotechnol; 2008 Jun; 26(6):321-7. PubMed ID: 18436317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme catalysed tandem reactions.
    Oroz-Guinea I; García-Junceda E
    Curr Opin Chem Biol; 2013 Apr; 17(2):236-49. PubMed ID: 23490810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the development of new biocatalytic processes for practical pharmaceutical synthesis.
    Huisman GW; Collier SJ
    Curr Opin Chem Biol; 2013 Apr; 17(2):284-92. PubMed ID: 23462589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoenzymatic synthesis of small molecule human therapeutics.
    Ran N; Rui E; Liu J; Tao J
    Curr Pharm Des; 2009; 15(2):134-52. PubMed ID: 19149609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocatalytic synthesis of enantiopure building blocks for pharmaceuticals.
    Simon RC; Mutti FG; Kroutil W
    Drug Discov Today Technol; 2013; 10(1):e37-44. PubMed ID: 24050228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric synthesis of active pharmaceutical ingredients.
    Farina V; Reeves JT; Senanayake CH; Song JJ
    Chem Rev; 2006 Jul; 106(7):2734-93. PubMed ID: 16836298
    [No Abstract]   [Full Text] [Related]  

  • 11. The importance of synthetic chemistry in the pharmaceutical industry.
    Campos KR; Coleman PJ; Alvarez JC; Dreher SD; Garbaccio RM; Terrett NK; Tillyer RD; Truppo MD; Parmee ER
    Science; 2019 Jan; 363(6424):. PubMed ID: 30655413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in industrial biocatalysis.
    Nestl BM; Nebel BA; Hauer B
    Curr Opin Chem Biol; 2011 Apr; 15(2):187-93. PubMed ID: 21195018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bio-Catalysis in Multicomponent Reactions.
    Jumbam ND; Masamba W
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33333902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halogenases: A Biotechnological Alternative for the Synthesis of Halogenated Pharmaceuticals.
    Ayala M; Segovia L; Torres E
    Mini Rev Med Chem; 2016; 16(14):1100-11. PubMed ID: 27337971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocatalytic routes to chiral amines and amino acids.
    Gotor-Fernández V; Gotor V
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):784-97. PubMed ID: 19894190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Industrial biotransformations in the synthesis of building blocks leading to enantiopure drugs.
    Muñoz Solano D; Hoyos P; Hernáiz MJ; Alcántara AR; Sánchez-Montero JM
    Bioresour Technol; 2012 Jul; 115():196-207. PubMed ID: 22230779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity-oriented synthesis.
    Spandl RJ; Díaz-Gavilán M; O'Connell KM; Thomas GL; Spring DR
    Chem Rec; 2008; 8(3):129-42. PubMed ID: 18563806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organolithium reagents in pharmaceutical asymmetric processes.
    Wu G; Huang M
    Chem Rev; 2006 Jul; 106(7):2596-616. PubMed ID: 16836294
    [No Abstract]   [Full Text] [Related]  

  • 20. New opportunities for biocatalysis: driving the synthesis of chiral chemicals.
    Zheng GW; Xu JH
    Curr Opin Biotechnol; 2011 Dec; 22(6):784-92. PubMed ID: 21783357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.